Stocktoria
Adagio Medical Holdings, Inc. ADGM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-02-26
Adagio Medical Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $0 | — | $300,000 |
| R&D expense | $10.6M | — | $15.4M |
| SG&A expense | $10.6M | — | $11.5M |
| Operating income | -$21.9M | — | -$27.9M |
| Income tax | $0 | $0 | $0 |
| Net income | -$25.1M | — | -$36.6M |
| EPS (diluted) | $-1.51 | — | $-48.16 |
| Operating cash flow | -$19.0M | — | -$25.7M |
| Free cash flow | -$19.4M | — | -$26.0M |
| Cash & equivalents | $17.1M | $20.6M | $1.4M |
| Inventory | $1.7M | $2.6M | $3.3M |
| Total assets | $43.3M | $48.4M | $6.8M |
| Total liabilities | $30.9M | $28.5M | $47.4M |
| Shareholders' equity | $12.4M | $19.9M | -$132.0M |
Source: SEC EDGAR filings · CIK 0002006986 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.